Navigation Links
Statement from Lilly and Avid on FDA Advisory Committee Recommendation for Amyvid™ (Florbetapir) NDA
Date:1/20/2011

INDIANAPOLIS and PHILADELPHIA, Jan. 20, 2011 /PRNewswire/ -- The U.S. Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee decided today that it could not recommend approval of Amyvid™ (florbetapir) at this time based on the currently available data (13-3); but, voted unanimously (16-0) to recommend approval of Amyvid conditional on a reader training program that demonstrates reader accuracy and consistency through a re-read of previously acquired scans. The Committee supported that efficacy was established and there were no significant safety concerns raised.

Amyvid is a molecular imaging tool under investigation for the detection of beta-amyloid plaque in the brain. The Committee stated that a negative scan would be clinically useful in indicating that Alzheimer's pathology is unlikely to be the cause of a patient's cognitive decline.

Lilly acquired Avid Radiopharmaceuticals, Inc. in December 2010. Amyvid is Avid's lead candidate and was the first beta-amyloid imaging compound to enter multi-center, investigational new drug (IND) clinical studies in the United States. Amyvid was recently assigned priority review designation by the FDA.

"We appreciate the careful and thoughtful review of our data today by the Committee," said Daniel M. Skovronsky, M.D., Ph.D., CEO, Avid Radiopharmaceuticals, Inc. "We are encouraged that they recommended a clear path toward approval."

The FDA will consider the panel's recommendation in its review of Amyvid. The FDA takes the advice of its Advisory Committees into consideration when reviewing investigational drugs, but is not bound by their recommendations.

About Amyvid

Amyvid is an imaging tool indicated for Positron Emission Tomography (PET) imaging of beta-amyloid plaque in the brain. It's being investigated for the potential use in ruling out Alzheimer's disease. In addition to the pivotal Phase III "Image-to-Autopsy" study,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. American Scientific Resources, Inc. Announces S-1 Registration Statement Effective; Commences Public Reporting Requirements
2. Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency
3. ThermoGenesis Corp. Files Shelf Registration Statement on Form S-3
4. Statement of Kenneth Stein, M.D., Chief Medical Officer, Cardiac Rhythm Management, Boston Scientific on JAMA Article
5. Cannabis Science Files Preliminary 14c Information Statement, the Action is to Create a New Class of Common Stock and Issue Dividend
6. PhRMA Statement on Department of Homeland Security Efforts to Crack Down on Counterfeiting Crimes
7. Lilly Statement Regarding President Obamas Meeting With U.S. Business Leaders
8. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
9. ERT Files Shelf Registration Statement
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... -- The Pharmaceutical Care Management Association (PCMA) issued ... offsets included in the Energy & Commerce Committee,s ... 21st Century Cures initiative can only be advanced by ... Medicare – then its costs outweigh any potential ... "Leveraging payments to Part D plans to ...
(Date:5/21/2015)...  Heidrick & Struggles (Nasdaq: HSII ), the ... consulting and culture shaping worldwide, strengthens ... announcing the addition of Tim Dietlin to ... Dietlin has extensive life sciences and professional ... Medical and Commercial functions to increase productivity, drive transformational ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 Research ... announced the addition of the "Global Next ... offering. The global next generation sequencing ... over the period 2014-2019 This report ... of the global next generation sequencing market for ...
Breaking Medicine Technology:Heidrick Increases Healthcare and Life Sciences Expertise 2Global Next Generation Sequencing Market 2015-2019 2
... Annual Meeting- , , ... of a randomized phase III study presented at the ... The study in adult patients with hematological malignancies at ... demonstrated that Elitek(R) (rasburicase) significantly reduced plasma uric acid ...
... Analgesic Significantly Reduces Postop Pain, Opioid Use, and ... Standard Pain Medication , ... A Phase II dose escalation study of a ... who underwent total knee arthroplasty, or TKA, showed ...
Cached Medicine Technology:Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 2Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 3Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 4Phase III Trial Results Show Elitek(R) (rasburicase) Significantly Reduced Plasma Uric Acid Levels versus Allopurinol in Adults with Hematologic Cancers at Risk for Tumor Lysis Syndrome 5Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 2Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 3Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress 4
(Date:5/22/2015)... 2015 Power Systems is proud to announce ... race season. Drobeck is in his second year of racing ... with the Missoula Fire Department in Missoula, MT. He entered ... 2014. During his career, he has had 15 1st Place ... top 10 finishes in all seven of his 2014 races, ...
(Date:5/22/2015)... Gateway Building Concepts is experienced with all ... company specialize in include decks, additions, kitchen remodeling, interior ... much more. , The redesigned logo is a ... company. It includes two geometrical lines that represent the ... to be used with many things associated with the ...
(Date:5/22/2015)... 2015 DMG Productions announces the upcoming ... broadcast on Friday, May 29, 2015 at 7:30 a.m. ... In this episode Innovations will explore Interstate Restoration, a ... quickly through disaster recovery and restoration. , Additionally, the ... collaboratively to develop and deliver training and education in ...
(Date:5/22/2015)... May 22, 2015 Co founders Greenlee and ... to allow general dentists to immediately deliver fully integrated dental ... on that of the medical surgeon. , The Center, ... roadblocks preventing general dentists from placing dental implants. These ... steps to introduce the surgical placement of dental implants into ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The ... letter calling on religious leaders to make changes in order ... on his blog, discusses the history of war, how it ... it. Yisrayl says mankind was created to lead peaceful, joyful ... society. , “Yahweh created mankind, according to His Plan, ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2
... Center is one of only 10 pediatric hospitals in the ... U.S.News & World Report,s America,s Best Children,s Hospitals ... serve children, 56 were ranked, and only an elite 10 ... coveted Honor Roll. The specific service lines surveyed included cancer, ...
... three national organizations representing nearly a third of a ... their continued concern for America,s patients who do not ... of Family Physicians (AAFP), the American College of Physicians ... majority of physicians who care for Medicare patients. The ...
... Members of Congress Seek Oncology Best Practices as First Step ... 18 U.S. Representatives Rep. Artur Davis (D-AL), Steve Israel ... the Medicare Quality Cancer Care Demonstration Act of 2009. ... to direct the Centers for Medicare & Medicaid Services (CMS) ...
... ... leadership must be strengthened and expanded at the individual, institutional, and network levels, Accordia ... ... outcomes in Africa over the long term, the continent’s healthcare leadership must be strengthened ...
... treatment of type 2 diabetes is not scientifically proven. Nor ... form, such as metformin and sulfonylureas. As a result, there ... been approved for 10 years and nateglinide for 8 years ... of longer duration than 14 months. This is the conclusion ...
... Nuu Rainforest Spring Water launches in the United States with several ... Appointments have already been set with several major distributors, ... having already approved the line for distribution , ... there is a place where nature shines. The ancient tribe ...
Cached Medicine News:Health News:Children's Named Among the Nation's Top 10 Pediatric Hospitals by U.S.News & World Report 2Health News:Call for primary care reform from AAFP, ACP and AOA 2Health News:Call for primary care reform from AAFP, ACP and AOA 3Health News:Call for primary care reform from AAFP, ACP and AOA 4Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 2Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 3Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 4Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 2Health News:Accordia Global Health Foundation Calls for Greater Investment to Build African Healthcare Leadership 3Health News:Benefit of glinides is not proven 2Health News:Benefit of glinides is not proven 3Health News:Next Generation Waters - Nuu 2
... Plates feature a unique design for easy ... CP titanium and .3mm thick for ease ... optimal malleability. Universal (left/right) anatomical shape for ... and smooth construction for optimal safety. Four ...
... Brown nucleus cracker with straight shaft ... viscoelastic, thereby, maintains anterior chamber depth ... Accomplished with a design that keeps ... blocking outflow of viscoelastic. Available with ...
Epilation forceps angled ends size 3.5"....
Forceps, delicate, straight....
Medicine Products: